 | NQ6 | Name: | N-(pyridin-2-yl)-L-asparagine | Formula: | C9 H11 N3 O3 | SMILES: | O=C(Nc1ccccn1)CC(N)C(=O)O | InChi: | InChI=1S/C9H11N3O3/c10-6(9(14)15)5-8(13)12-7-3-1-2-4-11-7/h1-4,6H,5,10H2,(H,14,15)(H,11,12,13)/t6-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2024-09-27 | Release date: | 2023-08-30 | Identifier: | N-(pyridin-2-yl)-L-asparagine |
|
 | PSW | Name: | 3-(SULFANYLSELANYL)-L-ALANINE | Formula: | C3 H7 N O2 S Se | SMILES: | O=C(O)C(N)C[Se]S | InChi: | InChI=1S/C3H7NO2SSe/c4-2(1-8-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 | Definition date: | 2009-08-07 | Last modified: | 2024-09-27 | Identifier: | 3-(sulfanylselanyl)-L-alanine |
|
 | XXA | Name: | 2,4,5-trideoxy-2-(methylamino)-4-[(2E)-penta-2,4-dien-1-yl]-L-xylonic acid | Formula: | C11 H19 N O3 | SMILES: | O=C(O)C(NC)C(O)C(C/C=C/C=C)C | InChi: | InChI=1S/C11H19NO3/c1-4-5-6-7-8(2)10(13)9(12-3)11(14)15/h4-6,8-10,12-13H,1,7H2,2-3H3,(H,14,15)/b6-5+/t8-,9+,10-/m1/s1 | Definition date: | 2010-11-19 | Last modified: | 2024-09-27 | Identifier: | 2,4,5-trideoxy-2-(methylamino)-4-[(2E)-penta-2,4-dien-1-yl]-L-xylonic acid |
|
 | PSX | Name: | [(2S,3R,4S)-2,4-DIHYDROXY-3-METHYLHEXYL]PHOSPHONIC ACID | Formula: | C7 H17 O5 P | SMILES: | O=P(O)(O)CC(O)C(C(O)CC)C | InChi: | InChI=1S/C7H17O5P/c1-3-6(8)5(2)7(9)4-13(10,11)12/h5-9H,3-4H2,1-2H3,(H2,10,11,12)/t5-,6+,7-/m1/s1 | Definition date: | 2006-06-06 | Last modified: | 2024-09-27 | Identifier: | [(2S,3R,4S)-2,4-dihydroxy-3-methylhexyl]phosphonic acid |
|
 | NCB | Name: | N-CARBAMOYL-ALANINE | Formula: | C4 H8 N2 O3 | SMILES: | O=C(O)C(NC(=O)N)C | InChi: | InChI=1S/C4H8N2O3/c1-2(3(7)8)6-4(5)9/h2H,1H3,(H,7,8)(H3,5,6,9)/t2-/m1/s1 | Definition date: | 1999-10-10 | Last modified: | 2024-09-27 | Identifier: | N-carbamoyl-D-alanine |
|
 | NQ9 | Name: | N-[[1-[4-azanyl-1-(4-chloranylphenoxy)cyclohexyl]carbonylpiperidin-4-yl]methyl]-2-chloranyl-ethanamide | Formula: | C21 H29 Cl2 N3 O3 | SMILES: | N[CH]1CC[C](CC1)(Oc2ccc(Cl)cc2)C(=O)N3CC[CH](CC3)CNC(=O)CCl | InChi: | InChI=1S/C21H29Cl2N3O3/c22-13-19(27)25-14-15-7-11-26(12-8-15)20(28)21(9-5-17(24)6-10-21)29-18-3-1-16(23)2-4-18/h1-4,15,17H,5-14,24H2,(H,25,27)/t17-,21+ | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | ~{N}-[[1-[4-azanyl-1-(4-chloranylphenoxy)cyclohexyl]carbonylpiperidin-4-yl]methyl]-2-chloranyl-ethanamide |
|
 | O5Y | Name: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C27 H29 Br N4 O4 | SMILES: | CCC(N5CC(NC(=O)Cn3cc(C(=O)N1Cc2c(CC1)c(ccc2)OC)c4cc(Br)ccc34)C5)=O | InChi: | InChI=1S/C27H29BrN4O4/c1-3-26(34)32-13-19(14-32)29-25(33)16-31-15-22(21-11-18(28)7-8-23(21)31)27(35)30-10-9-20-17(12-30)5-4-6-24(20)36-2/h4-8,11,15,19H,3,9-10,12-14,16H2,1-2H3,(H,29,33) | Definition date: | 2019-06-12 | Last modified: | 2024-09-27 | Release date: | 2019-08-28 | Identifier: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide |
|
 | PSY | Name: | phenyl ethenesulfonate | Formula: | C8 H8 O3 S | SMILES: | O=S(=O)(Oc1ccccc1)C=C | InChi: | InChI=1S/C8H8O3S/c1-2-12(9,10)11-8-6-4-3-5-7-8/h2-7H,1H2 | Definition date: | 2007-12-14 | Last modified: | 2024-09-27 | Identifier: | phenyl ethenesulfonate |
|
 | LBI | Name: | 4-methoxy-1H-indole-2-carbaldehyde | Formula: | C10 H9 N O2 | SMILES: | COc1cccc2[NH]c(cc21)C=O | InChi: | InChI=1S/C10H9NO2/c1-13-10-4-2-3-9-8(10)5-7(6-12)11-9/h2-6,11H,1H3 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 4-methoxy-1H-indole-2-carbaldehyde |
|
 | UMP | Name: | 2'-DEOXYURIDINE 5'-MONOPHOSPHATE | Formula: | C9 H13 N2 O8 P | SMILES: | O=P(O)(O)OCC2OC(N1C(=O)NC(=O)C=C1)CC2O | InChi: | InChI=1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 | Synonyms: | DUMP | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2'-deoxy-5'-uridylic acid |
|
 | S7Z | Name: | (E)-(4-((2,6-difluoro-4-(hydroxymethyl)phenyl)diazenyl)-2,6-difluorophenyl)methanol | Formula: | C14 H6 F4 N2 O4 | SMILES: | OC(=O)c1cc(F)c(N=Nc2c(F)cc(cc2F)C(O)=O)c(F)c1 | InChi: | InChI=1S/C14H6F4N2O4/c15-7-1-5(13(21)22)2-8(16)11(7)19-20-12-9(17)3-6(14(23)24)4-10(12)18/h1-4H,(H,21,22)(H,23,24)/b20-19- | Synonyms: | [4-[(~{Z})-[2,6-bis(fluoranyl)-4-(hydroxymethyl)phenyl]diazenyl]-3,5-bis(fluoranyl)phenyl]methanol | Definition date: | 2020-11-11 | Last modified: | 2024-09-27 | Release date: | 2021-12-15 | Identifier: | 4-[(~{Z})-[4-carboxy-2,6-bis(fluoranyl)phenyl]diazenyl]-3,5-bis(fluoranyl)benzoic acid |
|
 | X57 | Name: | (2R)-({[(3R,6S)-6-carbamoyl-1-formyl-4-methyl-1,2,3,6-tetrahydropyridin-3-yl]amino}oxy)(fluoro)acetic acid | Formula: | C10 H14 F N3 O5 | SMILES: | O=C(C1C=C(C)C(NOC(C(=O)O)F)CN1C=O)N | InChi: | InChI=1S/C10H14FN3O5/c1-5-2-7(9(12)16)14(4-15)3-6(5)13-19-8(11)10(17)18/h2,4,6-8,13H,3H2,1H3,(H2,12,16)(H,17,18)/t6-,7-,8-/m0/s1 | Definition date: | 2020-01-13 | Last modified: | 2024-09-27 | Release date: | 2020-08-26 | Identifier: | (2R)-({[(3R,6S)-6-carbamoyl-1-formyl-4-methyl-1,2,3,6-tetrahydropyridin-3-yl]amino}oxy)(fluoro)acetic acid |
|
 | KIH | Name: | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Formula: | C23 H23 F N4 O5 S | SMILES: | COc1ccc(cc1OC)c2c(C)nn3c(NCc4ccc(O[S](F)(=O)=O)cc4)cc(C)nc23 | InChi: | InChI=1S/C23H23FN4O5S/c1-14-11-21(25-13-16-5-8-18(9-6-16)33-34(24,29)30)28-23(26-14)22(15(2)27-28)17-7-10-19(31-3)20(12-17)32-4/h5-12,25H,13H2,1-4H3 | Definition date: | 2023-08-14 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine |
|
 | NCF | Name: | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}-5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | Formula: | C13 H14 N2 O5 S2 | SMILES: | S1CCC(C(O)=O)=NC1C(C=O)NC(=O)Cc2cccs2 | InChi: | InChI=1S/C13H14N2O5S2/c16-9(6-7-2-1-4-21-7)15-10(13(19)20)11-14-8(12(17)18)3-5-22-11/h1-2,4,10-11H,3,5-6H2,(H,15,16)(H,17,18)(H,19,20)/t10-,11+/m0/s1 | Synonyms: | NITROCEFIN, open form without dinitrophenyl-ethenyl group | Definition date: | 2004-10-01 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-[(1R)-2-oxo-1-{[(thiophen-2-yl)acetyl]amino}ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | RER | Name: | vancosamine | Formula: | C7 H15 N O3 | SMILES: | OC1OC(C(O)C(N)(C)C1)C | InChi: | InChI=1S/C7H15NO3/c1-4-6(10)7(2,8)3-5(9)11-4/h4-6,9-10H,3,8H2,1-2H3/t4-,5+,6+,7-/m0/s1 | Synonyms: | (1R,3S,4S,5S)-3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranose | Definition date: | 2010-09-06 | Last modified: | 2024-09-27 | Identifier: | 3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranose |
|
 | 4H0 | Name: | (3S)-3-amino-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid | Formula: | C11 H9 F4 N O4 | SMILES: | O=C(O)CC(C(=O)COc1c(F)c(F)cc(F)c1F)N | InChi: | InChI=1S/C11H9F4NO4/c12-4-1-5(13)10(15)11(9(4)14)20-3-7(17)6(16)2-8(18)19/h1,6H,2-3,16H2,(H,18,19)/t6-/m0/s1 | Definition date: | 2012-12-13 | Last modified: | 2024-09-27 | Release date: | 2013-03-20 | Identifier: | (3S)-3-amino-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
|
 | VUZ | Name: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C22 H20 Cl N7 O | SMILES: | CCn1cc(Nc2nc(Nc3cccc(NC(=O)C=C)c3)c4cc(Cl)ccc4n2)cn1 | InChi: | InChI=1S/C22H20ClN7O/c1-3-20(31)25-15-6-5-7-16(11-15)26-21-18-10-14(23)8-9-19(18)28-22(29-21)27-17-12-24-30(4-2)13-17/h3,5-13H,1,4H2,2H3,(H,25,31)(H2,26,27,28,29) | Definition date: | 2023-08-21 | Last modified: | 2024-09-27 | Release date: | 2024-08-21 | Identifier: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide |
|
 | O64 | Name: | 2-chloro-N-[(1S)-1-formylpropyl]-3-(trifluoromethyl)benzamide | Formula: | C12 H11 Cl F3 N O2 | SMILES: | FC(F)(F)c1cccc(C(=O)NC(C=O)CC)c1Cl | InChi: | InChI=1S/C12H11ClF3NO2/c1-2-7(6-18)17-11(19)8-4-3-5-9(10(8)13)12(14,15)16/h3-7H,2H2,1H3,(H,17,19)/t7-/m0/s1 | Definition date: | 2010-09-20 | Last modified: | 2024-09-27 | Identifier: | 2-chloro-N-[(2S)-1-oxobutan-2-yl]-3-(trifluoromethyl)benzamide |
|
 | RET | Name: | RETINAL | Formula: | C20 H28 O | SMILES: | O=CC=C(C=CC=C(C=CC1=C(C)CCCC1(C)C)C)C | InChi: | InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+ | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | retinal |
|
 | NQG | Name: | 5-AZANYLIDYNE-N-[(2S)-4-ETHOXY-2-HYDROXY-4-OXOBUTANOYL]-L-NORVALYL-L-ARGINYL-L-TRYPTOPHANAMIDE | Formula: | C28 H39 N9 O7 | SMILES: | O=C(OCC)CC(O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc2c1ccccc1nc2)CCCNC(=[N@H])N)CCC#N | InChi: | InChI=1S/C28H39N9O7/c1-2-44-23(39)14-22(38)27(43)36-19(9-5-11-29)25(41)35-20(10-6-12-33-28(31)32)26(42)37-21(24(30)40)13-16-15-34-18-8-4-3-7-17(16)18/h3-4,7-8,15,19-22,34,38H,2,5-6,9-10,12-14H2,1H3,(H2,30,40)(H,35,41)(H,36,43)(H,37,42)(H4,31,32,33)/t19-,20-,21-,22-/m0/s1 | Definition date: | 2006-11-09 | Last modified: | 2024-09-27 | Identifier: | 5-azanylidyne-N-[(2S)-4-ethoxy-2-hydroxy-4-oxobutanoyl]-L-norvalyl-L-arginyl-L-tryptophanamide |
|
 | KIK | Name: | (4~{S})-4-azanyl-5-oxidanyl-pent-1-en-3-one | Formula: | C5 H9 N O2 | SMILES: | N[CH](CO)C(=O)C=C | InChi: | InChI=1S/C5H9NO2/c1-2-5(8)4(6)3-7/h2,4,7H,1,3,6H2/t4-/m0/s1 | Definition date: | 2016-08-23 | Last modified: | 2024-09-27 | Release date: | 2017-01-18 | Identifier: | (4~{S})-4-azanyl-5-oxidanyl-pent-1-en-3-one |
|
 | V0Q | Name: | [4-(4-ethylpiperazin-1-yl)sulfonylphenyl]methanol | Formula: | C13 H20 N2 O3 S | SMILES: | CCN1CCN(CC1)[S](=O)(=O)c2ccc(CO)cc2 | InChi: | InChI=1S/C13H20N2O3S/c1-2-14-7-9-15(10-8-14)19(17,18)13-5-3-12(11-16)4-6-13/h3-6,16H,2,7-11H2,1H3 | Definition date: | 2021-04-01 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | [4-(4-ethylpiperazin-1-yl)sulfonylphenyl]methanol |
|
 | A1ADF | Name: | 4-{(E)-[4-(dimethylamino)phenyl]diazenyl}benzoic acid | Formula: | C15 H15 N3 O2 | SMILES: | CN(C)c1ccc(/N=N/c2ccc(cc2)C(=O)O)cc1 | InChi: | InChI=1S/C15H15N3O2/c1-18(2)14-9-7-13(8-10-14)17-16-12-5-3-11(4-6-12)15(19)20/h3-10H,1-2H3,(H,19,20)/b17-16+ | Definition date: | 2024-01-21 | Last modified: | 2024-09-27 | Release date: | 2024-08-07 | Identifier: | 4-{(E)-[4-(dimethylamino)phenyl]diazenyl}benzoic acid |
|
 | U9O | Name: | 5-azanyl-1-oxidanyl-pentan-2-one | Formula: | C5 H11 N O2 | SMILES: | NCCCC(=O)CO | InChi: | InChI=1S/C5H11NO2/c6-3-1-2-5(8)4-7/h7H,1-4,6H2 | Definition date: | 2023-08-31 | Last modified: | 2024-09-27 | Release date: | 2024-02-21 | Identifier: | 5-azanyl-1-oxidanyl-pentan-2-one |
|
 | X5C | Name: | N-[(2S)-1-[[(2S)-1-[[(1S)-1-[(2S,3R,5S,6R)-3-(hydroxymethyl)-5-methanoyl-2,3,6-trimethyl-morpholin-2-yl]-2-phenyl-ethyl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]hexanamide | Formula: | C45 H56 N6 O6 | SMILES: | CCCCCC(=O)N[CH](Cc1c[nH]c2ccccc12)C(=O)N[CH](Cc3c[nH]c4ccccc34)C(=O)N[CH](Cc5ccccc5)[C]6(C)O[CH](C)[CH](N[C]6(C)CO)C=O | InChi: | InChI=1S/C45H56N6O6/c1-5-6-8-21-41(54)48-37(23-31-25-46-35-19-13-11-17-33(31)35)42(55)49-38(24-32-26-47-36-20-14-12-18-34(32)36)43(56)50-40(22-30-15-9-7-10-16-30)45(4)44(3,28-53)51-39(27-52)29(2)57-45/h7,9-20,25-27,29,37-40,46-47,51,53H,5-6,8,21-24,28H2,1-4H3,(H,48,54)(H,49,55)(H,50,56)/t29-,37+,38+,39-,40+,44-,45+/m1/s1 | Synonyms: | proteasome inhibitor CP-17 | Definition date: | 2023-05-31 | Last modified: | 2024-09-27 | Release date: | 2024-05-22 | Identifier: | ~{N}-[(2~{S})-1-[[(2~{S})-1-[[(1~{S})-1-[(2~{S},3~{R},5~{S},6~{R})-3-(hydroxymethyl)-5-methanoyl-2,3,6-trimethyl-morpholin-2-yl]-2-phenyl-ethyl]amino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1~{H}-indol-3-yl)-1-oxidanylidene-propan-2-yl]hexanamide |
|